Sherene Loi, Medical Oncologist, Lab Head of Breast Oncology Clinical Trials at Peter MacCallum Cancer Centre, shared on X:
“Sharing our latest article: Here we show that dose dense AC-T, radiotherapy and age affects long-term lymphocyte counts post adjuvant breast cancer treatment ?implications for IO therapy.”
Sustained lymphocyte decreases after treatment for early breast cancer
Authors: Julia Dixon-Douglas, Balaji Virassamy, Kylie Clarke, Michael Hun, Stephen J. Luen, Peter Savas, Courtney T. van Geelen, Steven David, Prudence A. Francis, Roberto Salgado, Stefan Michiels, Sherene Loi
More posts featuring Immunotherapy on oncodaily.com